Assess whether pediatric studies are necessary or waivable (d1506b)

Situation

In a labeling team facing a boxed-warning debate, disproportionate reporting signal workbook is the evidence after a DSMB note on an imbalance that is not yet a signal. Pharmacovigilance medical reviewer has to pick Pediatric studies are necessary or Waivable for this Pharma & Life Sciences Pharmacovigilance close using disproportionate reporting signal workbook.

Decision

Pharmacovigilance medical reviewer in a labeling team facing a boxed-warning debate must choose Pediatric studies are necessary / Waivable using disproportionate reporting signal workbook after a DSMB note on an imbalance that is not yet a signal.

Hypotheses to test

• A DSMB note on an imbalance that is not yet a signal is noise around an already-controlled Pharmacovigilance process in a labeling team facing a boxed-warning debate, given disproportionate reporting signal workbook.
• A DSMB note on an imbalance that is not yet a signal is the event in disproportionate reporting signal workbook that forces Pediatric studies are necessary for pharmacovigilance medical reviewer under Pharma & Life Sciences.
• Disproportionate reporting signal workbook shows a one-file miss after a DSMB note on an imbalance that is not yet a signal, not a Pharmacovigilance program failure.
• Disproportionate reporting signal workbook cannot decide pediatric studies are necessary yet after a DSMB note on an imbalance that is not yet a signal; hold is the only Pharma & Life Sciences close a labeling team facing a boxed-warning debate can defend.

Analysis required

• Check whether disproportionate reporting signal workbook supports the labeled claim pharmacovigilance medical reviewer would keep.
• Map FDA-response timing and owner in a labeling team facing a boxed-warning debate.
• Trace CMC, labeling, or pharmacovigilance facts in disproportionate reporting signal workbook after a DSMB note on an imbalance that is not yet a signal.
• For this Pharma & Life Sciences Pharmacovigilance file, read disproportionate reporting signal workbook against a DSMB note on an imbalance that is not yet a signal and write the one fact that would move pediatric studies are necessary for pharmacovigilance medical reviewer.

Recommendation

Choose Pediatric studies are necessary / Waivable on this Pharma & Life Sciences / Pharmacovigilance packet (disproportionate reporting signal workbook after a DSMB note on an imbalance that is not yet a signal). Lead with the Pharma & Life Sciences option disproportionate reporting signal workbook can support after a DSMB note on an imbalance that is not yet a signal, then the two facts that force it, then the Monday action for pharmacovigilance medical reviewer in a labeling team facing a boxed-warning debate.